Ultimovacs (ULTI) – Corporate News
-
Ultimovacs (ULTI) Announces Publication in The Journal of Translational Medicine on Mechanistic Rationale of UV1 Cancer Vaccine Supporting Phase 2 Study Design in Malignant Mesothelioma
-
Ultimate Software Group (ULTI) Completes Agreement to be Acquired by Hellman & Friedman
-
-
-
-
-
-
-
-
-
-
-
-
Back to ULTI Stock Lookup